IDEXX Laboratories (NASDAQ:IDXX) Updates FY 2023 Earnings Guidance

IDEXX Laboratories (NASDAQ:IDXX – Get Free Report) issued an update on its FY 2023 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $9.64-$9.90 for the period, compared to the consensus earnings per share estimate of $9.69. The company issued revenue guidance of $3.66 billion-$3.71 billion, compared to the consensus revenue […]

Related Keywords

Jonathanw Ayers , ,Companion Animal Group ,Laboratories Inc ,Strategic Investment Solutions Inc ,Jpmorgan Chase Co ,Fortis Capital Advisors ,Carolinas Wealth Consulting ,Resurgent Financial Advisors ,Altshuler Shaham Ltd ,Morgan Stanley ,Get Free Report ,Trading Down ,Moderate Buy ,Director Jonathan ,Shaham Ltd ,Financial Advisors ,Investment Solutions ,Wealth Consulting ,Water Quality Products ,Idexx Laboratories ,Nasdaq Idxx ,Idxx ,Medical ,45168d10 ,Guidance ,Earnings ,Preannouncement ,